Daniel J. Silver

Cleveland Clinic Lerner College of Medicine — United States

Medicine · Health Sciences

28h-index3.4kcitations238works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(44), Immune cells in cancer(38), Cancer Cells and Metastasis(30), Cancer Immunotherapy and Biomarkers(25), Epigenetics and DNA Methylation(25)

Publications238 total

Lipocalin 2 orchestrates resistance to ferroptosis via AXL
Cell Reports·2026Open Access
Supplementary Figures S1-S16 from Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
2025Open Access
Supplementary Tables S1-S2 from Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
2025Open Access
ObliQ: Solving Quadratic Unconstrained Binary Optimization Problems on Real Photonic Quantum Machines
Proceedings of the ACM on Measurement and Analysis of Computing Systems·2025Open Access
Supplementary Data from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
2025Open Access
Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
2025Open Access
Opposing functions of white matter in glioblastoma
Neuro-Oncology·2025Open Access
EXTH-67. Beneficial effects of TAT-Cx43266-283 in combination with tumor resection in preclinical GBM models
Neuro-Oncology·2025Open Access
TMET-29. Sulfide oxidation activity is essential for mitochondrial respiration and growth in glioblastoma
Neuro-Oncology·2025Open Access
Androgen loss weakens anti-tumor immunity and accelerates brain tumor growth 3761
The Journal of Immunology·2025Open Access
IMMU-02. Microglia Depletion Demonstrates a Time-dependent But Sex-independent Decrease in Survival in a Murine Model of Glioblastoma
Neuro-Oncology·2025Open Access
IMMU-20. Platelets drive immune suppression and glioblastoma growth in a sex-dependent manner via PAR4 signaling
Neuro-Oncology·2025
TMET-56. Targeting transsulfuration via suppression of thyroid hormone signaling: a modified phase 1/2 and pharmacodynamic trial of methimazole in patients with progressive WHO grade 4 gliomas
Neuro-Oncology·2025Open Access
CSIG-09. A CX43-WNK1-C-MYC SIGNALING AXIS DRIVES GLIOBLASTOMA CANCER STEM CELL GROWTH AND SURVIVAL
Neuro-Oncology·2025Open Access
Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis
Cell Reports·2025· 2 citedOpen Access
Platelets drive immune suppression and glioblastoma growth in a sex-dependent manner via PAR4 signaling
2025Open Access
The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular Carcinoma
2025· 1 citedOpen Access
OpaQue: Program Output Obfuscation for Quantum Software Circuits in Quantum Clouds
2025Open Access
Tumor cell–derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition
Journal of Clinical Investigation·2024· 12 citedOpen Access
Intestinal stem cells enhance local mucosal immunity through apoptotic body phagocytosis
2024· 2 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Justin D. Lathia(34), Defne Bayık(15), Erin E. Mulkearns-Hubert(9), Tyler Alban(9), Soumya M. Turaga(8), Dennis A. Steindler(7), Michael A. Vogelbaum(7), Dionysios C. Watson(7), Matthew M. Grabowski(7), Kristen Kay(7), Florian A. Siebzehnrübl(6), Adam Lauko(6), Gustavo Roversi(6), Manmeet S. Ahluwalia(6), Ofer Reizes(6), Juyeun Lee(6), J. Mark Brown(6), James S. Hale(5), Jeremy N. Rich(5), Jerry Silver(5)